Comprehensive Drug Enterprises Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Comprehensive Drug Enterprises General Information
Description
Developer of drugs and medical devices. The company offers research and development of medical devices and drugs focusing on sub lingual and nasal drugs.
Contact Information
Website
www.cdepharma.comCorporate Office
- Unit 811-813, IC Development Centre
- Number 6 Science Park West Avenue, Hong Kong Science Park
- Hong Kong
- Hong Kong
Corporate Office
- Unit 811-813, IC Development Centre
- Number 6 Science Park West Avenue, Hong Kong Science Park
- Hong Kong
- Hong Kong
Comprehensive Drug Enterprises Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Comprehensive Drug Enterprises Comparisons
Industry
Financing
Details
Comprehensive Drug Enterprises Competitors (6)
One of Comprehensive Drug Enterprises’s 6 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Biocon | Formerly PE-Backed | Bengaluru, India |
Comprehensive Drug Enterprises Patents
Comprehensive Drug Enterprises Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2013384818-A1 | Ophthalmic composition, method for preparing the same, and use of the same | Inactive | 27-Mar-2013 | ||
| EP-2978409-A1 | Ophthalmic composition, method for preparing the same, and use of the same | Active | 27-Mar-2013 | ||
| EP-2978409-A4 | Ophthalmic composition, method for preparing the same, and use of the same | Active | 27-Mar-2013 | ||
| EP-2978409-B1 | Ophthalmic composition, method for preparing the same, and use of the same | Inactive | 27-Mar-2013 | ||
| US-20160074321-A1 | Ophthalmic composition, method for preparing the same, and use of the same | Inactive | 27-Mar-2013 | A61K9/0048 |
Comprehensive Drug Enterprises FAQs
-
When was Comprehensive Drug Enterprises founded?
Comprehensive Drug Enterprises was founded in 2005.
-
Where is Comprehensive Drug Enterprises headquartered?
Comprehensive Drug Enterprises is headquartered in Hong Kong, Hong Kong.
-
What industry is Comprehensive Drug Enterprises in?
Comprehensive Drug Enterprises’s primary industry is Drug Delivery.
-
Is Comprehensive Drug Enterprises a private or public company?
Comprehensive Drug Enterprises is a Private company.
-
What is the current valuation of Comprehensive Drug Enterprises?
The current valuation of Comprehensive Drug Enterprises is .
-
What is Comprehensive Drug Enterprises’s current revenue?
The current revenue for Comprehensive Drug Enterprises is .
-
Who are Comprehensive Drug Enterprises’s competitors?
Genentech, Pfizer Manufacturing Austria, Novartis, Merck & Co., and Biocon are some of the 6 competitors of Comprehensive Drug Enterprises.
-
When was Comprehensive Drug Enterprises acquired?
Comprehensive Drug Enterprises was acquired on 14-Dec-2015.
-
Who acquired Comprehensive Drug Enterprises?
Comprehensive Drug Enterprises was acquired by Athenex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
